Does caffeine shampoo work for hair loss? What the evidence shows
Human studies offer some encouraging findings. What matters is which formula was tested, how it was used and what actually changed.

The useful takeaway
Caffeine shampoo has some human evidence, but it is too limited to promise regrowth or establish that any bottle will treat hair loss. A leave-on liquid and a shampoo with several active ingredients cannot answer the same question.
The short answer
Caffeine shampoo is worth discussing with realistic expectations: some studies in people report benefits, but the evidence does not justify a general promise of hair regrowth. Saying there is no human evidence would also be wrong. The useful question is whether a particular shampoo has reliable evidence for the problem you want it to address. [1] [3]
If you have noticed more hair in your brush, it is understandable to want a simple answer from the bathroom shelf. You deserve an explanation that goes beyond an ingredient name. Start by separating a product you enjoy washing with from a treatment decision about thinning hair.
What did the 2025 review find?
A systematic review found nine trials involving 684 people: four studied rinse-off products and five leave-on preparations. Its search ended on 29 November 2024, before the newer shampoo trial below. The reviewers rated three studies as medium-quality evidence, one low and five very low. Missing controls, lack of randomisation and undisclosed caffeine concentrations weakened the picture. Five trials tested mixtures. [1]
The review was funded by Jagiellonian University Medical College; its authors declared no conflicts of interest. It provides a useful overview, rather than a verdict on every shampoo currently sold.
Was caffeine as effective as minoxidil?
A 2017 randomised trial compared a 0.2% caffeine leave-on liquid with 5% minoxidil solution in 210 men with male pattern hair loss over six months. The main measure was the change in the proportion of hairs in their growing phase. Caffeine met the study’s pre-set noninferiority margin on that measure. This does not establish equal visible regrowth, or effectiveness for a rinse-off shampoo. [2]
Participants and investigators knew which treatment was used; there was no placebo group. Dr Kurt Wolff funded the study, and authors included a company employee and consultant. Those limitations belong alongside the result.
What does the newer shampoo trial add?
In 2025, a 24-week double-blind, randomised, placebo-controlled trial studied 154 men with male pattern hair loss. Its shampoo combined 1% caffeine with 1% sodium dimethylglycinate (DMG-Na). The main outcome, a hair-pull test, favoured the active shampoo. Photographic measurements in only 30 participants also favoured it; standardised whole-head photographs were absent. [3]
This supports further interest in that combination, but cannot isolate caffeine’s contribution. Dr Kurt Wolff funded the work; two authors worked there and another at its sister company. Follow-up was limited. No adverse events were reported, which cannot establish that a product will be free of side effects for everyone.
Why “works” needs a clearer meaning
Before comparing claims, decide what you mean by improvement. Would it be less shedding, a visibly fuller parting, or simply hair that feels easier to style? These are different questions. A change in a study measurement needs to be connected to the result you care about; the word “effective” alone leaves that connection unclear.
Laboratory research can help explain why an ingredient is interesting. A result in isolated cells or follicles does not, by itself, show what happens when someone uses a finished shampoo at home. Likewise, measuring whether an ingredient reaches a follicle is a different question from whether the user sees lasting improvement.
Ask for the evidence behind the exact claim. Useful questions include:
- Was the finished formula studied, or just one ingredient?
- Was it washed off or left on, and were other active ingredients included?
- Did the study include people with the same kind of hair loss?
- What changed, compared with what, and over how long?
- Who funded the work, and has another research group tested the finding?
You do not need to become a researcher to ask these questions. If the product page provides only a percentage or a striking photograph, look for a link to the study and a clear account of its limits before treating the claim as a reason to spend more.
What about the UK advertising ruling?
The ASA’s hair-loss guidance describes a 2018 Alpecin ruling: the submitted evidence did not adequately support that product’s claim to reduce hair loss. That decision concerned particular advertising and evidence. It should not be stretched into a claim that every later formulation has been disproved, or that no human research exists.
Choose the next step around your hair loss
If you are worried about hair loss, the NHS advises seeing a GP. Understanding the cause is more useful than repeatedly changing shampoos. Tell them if it is affecting your confidence or wellbeing, too. You do not have to minimise that part of the experience.
If you are already considering treatment, the NHS notes that minoxidil does not work for everyone and its benefit depends on continued use. Our UK hair-loss options guide explains the existing product choices and label checks. It is an optional next step, not evidence that the shampoos discussed here are equivalent to those medicines.
For an everyday shampoo purchase, keep your budget and expectations in view. You can choose a product for how it fits your routine without paying extra for an uncertain regrowth claim. None of these papers can tell you what your own result will be.
Before shopping: medicine and cosmetic shampoo are different
The caffeine research above is not evidence that a registered Nioxin shampoo is the studied formulation or a proven regrowth treatment. A cosmetic shampoo and a licensed minoxidil medicine answer different questions.
Our comparison guide separates cosmetic shampoo from the exact UK Regaine labels. The men’s 5% foam is labelled for men aged 18–49, twice daily; the women’s 5% foam for women aged 18–65, once daily. Their directions are not interchangeable. Read the full leaflet and ask a pharmacist about suitability. Sudden, patchy, unexplained or post-childbirth hair loss needs assessment before choosing treatment.
The sources behind this article
A 2025 systematic review, a 2017 leave-on liquid trial and a newer 2025 combination-shampoo trial. The formulations, outcomes and funding matter as much as the positive findings.
- Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence
Szendzielorz E and Spiewak R (2025). Healthcare.
Systematic review of human clinical trials. Search closed November 2024. Mixed formulations and evidence quality; university funding, no declared conflicts. - An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia
Dhurat R, Chitallia J, May TW, Jayaraaman AM, Madhukara J, Anandan S, Vaidya P and Klenk A (2017). Skin Pharmacology and Physiology.
Open-label randomised noninferiority trial. PMID 29055953. Leave-on liquid; growing-phase endpoint. Manufacturer funding and author ties. - A Novel Approach Against Male Pattern Hair Loss With Topical Dimethylglycine Sodium Salt (DMG-Na) and Caffeine: Efficacy of a 24-Week, Double-Blind, Randomized, Placebo-Controlled Trial
Celleno L, Bussoletti C, Tolaini MV, Rossi A, Ala L, Becker M, Völker JM and Schulze Zur Wiesche E (2025). Journal of Cosmetic Dermatology.
Double-blind randomised placebo-controlled trial. PMID 40820949. Combination shampoo; small photographic subgroup. Manufacturer funding and employee authors.
About this article
AI-assisted writing and source checks by Glowwy editorial. This is general information, not individual medical advice or a clinically reviewed treatment recommendation. Read our editorial policy and corrections process.